Home » Authors » Nuala Moran

Nuala Moran

Articles

ARTICLES

Acambis, Berna Enter Alliance To Create Combination Vaccine

March 21, 2001

Matrix Secures £2M In First Round For Drugs, Diagnostics

March 21, 2001

Vernalis, Lilly Extend Deal On Sexual Dysfunction Drug

March 21, 2001

PPL Braves Tough Market In Public Attempt To Raise £45M

March 21, 2001

Acambis, Berna Enter Alliance To Create Combination Vaccine

March 21, 2001

Gendaq Says Zinc Finger Platform Ready For Regulation Of Genes

March 14, 2001

RiboTargets Signs Deal With J&J, Plans Financing Round Of £20M

March 14, 2001

Oxford BioMedica Seeks £40M As It Moves To London Exchange

March 14, 2001

Gendaq Says Zinc Finger Platform Ready For Regulation Of Genes

March 14, 2001

RiboTargets Signs Deal With J&J, Plans Financing Round Of £20M

March 14, 2001

View All Articles by Nuala Moran

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 14, 2025.
European VCs optimistic for med-tech exit opportunities in 2025
BioWorld MedTech
To say that European investors are optimistic about the outlook for the med-tech sector in 2025 is an understatement. A couple of companies are already listed on...
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for February 14, 2025
European VCs bullish on med-tech investments in 2025
BioWorld MedTech
European companies looking for capital should find the fundraising environment more favorable in 2025. Private med-tech financings in January totaled about $2...
Kura/Kyowa Kirin’s ziftomenib hits phase II endpoints in AML
BioWorld
Kura Oncology Inc. and Kyowa Kirin Co. Ltd.’s selective oral menin inhibitor, ziftomenib, met the primary endpoints in the phase II registrational Komet-001 trial...